U.S. Centers for Disease Control and Prevention, National Institute of Allergy and Infectious Diseases, National Institute of General Medical Sciences, and Alexander von Humboldt Foundation.
<span><b>Objective:</b> By analyzing the epidemic characteristics and related indicators of SARS and COVID-19, to explore the reasons for the similarities and differences of the two epidemics, so as to provide reference for epidemic...
Care for Critically Ill Patients With COVID-19
Virtually Perfect? Telemedicine for Covid-19
How will country-based mitigation measures influence the course of the COVID-19 epidemic?
The recent outbreak of coronavirus infectious disease 2019 (COVID-19) has gripped the world with apprehension and has evoked a scare of epic proportion regarding its potential to spread and infect humans worldwide. As we are in the midst...
Since the emergence of coronavirus disease 2019 (COVID-19) (formerly known as the 2019 novel coronavirus [2019-nCoV]) in Wuhan, China in December 2019, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), more...
<span><b>OBJECTIVE.</b> Available information on CT features of the 2019 novel coronavirus disease (COVID-19) is scattered in different publications, and a cohesive literature review has yet to be compiled. <b>MATERIALS AND METHODS.</b>...
Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1
The impact of high-flow nasal cannula (HFNC) on coughing distance: implications on its use during the novel coronavirus disease outbreak
Try “site:ncbi.nlm.nih.gov” on: Marginalia · Mojeek · Wiby · DuckDuckGo · Bing · Google · Wikipedia · Internet Archive